ORODISPERSIBLE TABLETS MARKET ANALYSIS

Market Challenges And Opportunities

Global Orodispersible Tablets Market- Drivers

• Increasing Prevalence of Chronic Diseases: The growing burden of chronic diseases such as cardiovascular disorders, diabetes, and neurological conditions boosts demand for efficient drug delivery systems like orodispersible tablets. These tablets offer advantages such as easy administration, rapid onset of action, and improved patient compliance, and thus, contributing to market growth. Moreover, increasing prevalence of chronic disease in the U.S. is expected to drive the market growth over the forecast period. For instance, in July 2021, according to the data published by Centers of Disease Control and Prevention (CDC), six in 10 adults in U.S. have a chronic disease and four in ten adults have two or more chronic diseases.
• Technological Advancements in Drug Delivery: Advances in drug delivery technologies have enabled the development of innovative orodispersible tablet formulations. These technologies enhance the taste, stability, and bioavailability of drugs, and thus, leading to improved therapeutic outcomes. The continuous research and development efforts in this field boosts growth of the orodispersible tablets market. Moreover, increasing inorganic strategies such as acquisition is expected to drive the market growth over the forecast period. For instance, in November 2020, Novo Nordisk A/S, one of the leading global healthcare company, entered into a definitive agreement to acquire Emisphere Technologies Inc., a drug delivery company with proprietary technologies such as the Eligen SNAC technology that enable oral formulations of therapeutics.
• Enhanced Patient Compliance and Convenience: Orodispersible tablets offer a user-friendly and convenient method of drug administration, particularly for patients who have difficulty swallowing tablets or who prefer an alternative to liquid medications. The ease of administration improves patient compliance, resulting in better treatment outcomes and driving market growth.
• Growing Focus on Patient-Centered Care: The healthcare industry's increasing emphasis on patient-centered care and enhancing patient experience boosts demand for patient-friendly drug delivery methods. Orodispersible tablets offer a convenient and pleasant experience for patients, leading to improved satisfaction and driving the market growth.

Global Orodispersible Tablets Market- Opportunities

• Expanding Applications in Pediatric and Geriatric Care: Orodispersible tablets offer significant opportunities in pediatric and geriatric care, where medication administration can be challenging. Developing age-appropriate formulations and flavors for children, as well as catering to the specific needs of the elderly population can open up new market segments and drive the market growth.
• Targeting Underdeveloped Markets: There are opportunities to expand the adoption of orodispersible tablets in underdeveloped markets where awareness and access to advanced drug delivery systems are limited. Educating healthcare professionals and patients about the benefits of orodispersible tablets and partnering with local stakeholders can help tap into these emerging markets.
• Customized Formulations for Specific Therapeutic Areas: Designing orodispersible tablets with customized formulations for specific therapeutic areas presents opportunities for market growth. Tailoring formulations to address the unique needs of different diseases such as cardiovascular disorders, neurodegenerative diseases, and mental health conditions can offer targeted treatment options and expand market reach.
• Strategic Partnerships with Pharmaceutical Companies: Collaborating with pharmaceutical companies to develop orodispersible tablet formulations for their existing drug portfolios presents opportunities for market expansion. Partnering with established pharmaceutical manufacturers can leverage their expertise, resources, and market presence, facilitating the development and commercialization of new orodispersible tablet products.

Global Orodispersible Tablets Market- Restraints

• High Development and Manufacturing Costs: The development and manufacturing of orodispersible tablets can involve complex processes and specialized equipment, and thus, leading to higher costs compared to conventional tablets. The investment required for research, formulation development, taste-masking technologies, and production can pose a challenge, particularly for smaller pharmaceutical companies.
• Limited Drug Compatibility and Formulation Options: Not all drugs are suitable for formulating into orodispersible tablets due to stability, bioavailability, or compatibility issues. Some drugs require specific delivery systems or have characteristics that make them unsuitable for quick-dissolving formulations, limiting the range of drugs that can be developed as orodispersible tablets.

Global Orodispersible Tablets Market- Trends

• Increasing Demand for Personalized Medicine: There is a growing trend towards personalized medicine due to advancements in genomics and precision healthcare. This trend extends to the orodispersible tablets market, with a focus on developing tailored formulations and dosing regimens to meet individual patient needs and optimize treatment outcomes.
• Rising Adoption of Digital Health Solutions: The integration of digital health solutions such as mobile apps, wearable devices, and telemedicine is gaining traction in the orodispersible tablets market. These technologies enable remote patient monitoring, medication adherence tracking, and personalized healthcare management, enhancing patient engagement and improving treatment outcomes.
• Development of Innovative Taste-Masking Techniques: Taste-masking techniques are advancing to enhance the flavor appeal of orodispersible tablets. In the quest for improved patient experience, producers are investigating inventive approaches to conceal the taste of active ingredients, ultimately rendering the tablets more enjoyable for consumption. This trend aims to address taste-related challenges, particularly in pediatric and geriatric populations.
• Focus on Fast-Dissolving Formulations: Rapid disintegration and dissolution of orodispersible tablets are becoming key factors in product development. Manufacturers are focusing on improving the formulation properties to ensure quick and complete dissolution in the mouth, allowing for faster onset of action and enhanced patient convenience.